Notable Labs, Ltd. (NASDAQ: NTBL) had its price target lowered by analysts at Chardan Capital from $7.00 to $5.00. They now have a "buy" rating on the stock.
Notable Labs to Participate in Fireside Chat at the Citizens JMP Securities Life Sciences Conference 2024
Notable Labs, Ltd. (NASDAQ: NTBL) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $9.00 price target on the stock.
Notable Labs, Ltd. (NASDAQ: NTBL) had its price target lowered by analysts at Chardan Capital from $9.00 to $7.00. They now have a "buy" rating on the stock.
Notable Labs Reports 2023 Financial Results and Provides a Business Update